Praziquantel indications and usage: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Indications and Usage== | ==Indications and Usage== | ||
BILTRICIDE is indicated for the treatment of infections due to: all species of schistosoma (for example, [[Schistosoma mekongi]], [[Schistosoma japonicum]], [[Schistosoma mansoni]] and [[Schistosoma haematobium]]), and infections due to the liver flukes, [[Clonorchis sinensis]]/[[Opisthorchis viverrini]] (approval of this indication was based on studies in which the two species were not differentiated).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BILTRICIDE (PRAZIQUANTEL) TABLET, FILM COATED [BAYER HEALTHCARE PHARMACEUTICALS INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9 | publisher = | date = | accessdate = }}</ref> | BILTRICIDE is indicated for the treatment of infections due to: all species of [[schistosoma]] (for example, [[Schistosoma mekongi]], [[Schistosoma japonicum]], [[Schistosoma mansoni]] and [[Schistosoma haematobium]]), and infections due to the liver flukes, [[Clonorchis sinensis]]/[[Opisthorchis viverrini]] (approval of this indication was based on studies in which the two species were not differentiated).<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BILTRICIDE (PRAZIQUANTEL) TABLET, FILM COATED [BAYER HEALTHCARE PHARMACEUTICALS INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 04:16, 12 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Indications and Usage
BILTRICIDE is indicated for the treatment of infections due to: all species of schistosoma (for example, Schistosoma mekongi, Schistosoma japonicum, Schistosoma mansoni and Schistosoma haematobium), and infections due to the liver flukes, Clonorchis sinensis/Opisthorchis viverrini (approval of this indication was based on studies in which the two species were not differentiated).[1]
References
Adapted from the FDA Package Insert.